Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GFAP Antikörper (N-Term)

GFAP Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN357395
  • Target Alle GFAP Antikörper anzeigen
    GFAP (Glial Fibrillary Acidic Protein (GFAP))
    Bindungsspezifität
    • 30
    • 27
    • 21
    • 16
    • 16
    • 13
    • 9
    • 9
    • 8
    • 7
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 297
    • 177
    • 170
    • 54
    • 53
    • 37
    • 34
    • 13
    • 13
    • 11
    • 11
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 193
    • 144
    • 12
    • 3
    • 2
    • 1
    Kaninchen
    Klonalität
    • 194
    • 161
    Polyklonal
    Konjugat
    • 166
    • 29
    • 25
    • 19
    • 13
    • 9
    • 8
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser GFAP Antikörper ist unkonjugiert
    Applikation
    • 287
    • 129
    • 101
    • 87
    • 74
    • 63
    • 45
    • 30
    • 26
    • 26
    • 25
    • 23
    • 13
    • 8
    • 8
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
    Spezifität
    This antibody detects GFAP N-term.
    Aufreinigung
    Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
    Immunogen
    This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human GFAP.
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product GFAP Primärantikörper
  • Applikationshinweise
    ELISA 1: 1,000. Western blot 1: 100 - 1: 500. Immunohistochemistry 1: 50 - 1: 100.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.25 mg/mL
    Buffer
    PBS with 0.09 % (W/V) sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
  • Curtis, Martin, Gabel, Sidhu, Rzesiewicz, Mandeville, Van Gorp, Leerink, Tadokoro, Marsala, Jamieson, Marsala, Ciacci: "A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury." in: Cell stem cell, Vol. 22, Issue 6, pp. 941-950.e6, (2018) (PubMed).

    Kadoya, Lu, Nguyen, Lee-Kubli, Kumamaru, Yao, Knackert, Poplawski, Dulin, Strobl, Takashima, Biane, Conner, Zhang, Tuszynski: "Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration." in: Nature medicine, Vol. 22, Issue 5, pp. 479-87, (2017) (PubMed).

    Lu, Ceto, Wang, Graham, Wu, Kumamaru, Staufenberg, Tuszynski: "Prolonged human neural stem cell maturation supports recovery in injured rodent CNS." in: The Journal of clinical investigation, Vol. 127, Issue 9, pp. 3287-3299, (2017) (PubMed).

    Miyanohara, Kamizato, Juhas, Juhasova, Navarro, Marsala, Lukacova, Hruska-Plochan, Curtis, Gabel, Ciacci, Ahrens, Kaspar, Cleveland, Marsala: "Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs." in: Molecular therapy. Methods & clinical development, Vol. 3, pp. 16046, (2016) (PubMed).

  • Target
    GFAP (Glial Fibrillary Acidic Protein (GFAP))
    Andere Bezeichnung
    GFAP (GFAP Produkte)
    Synonyme
    GFAP antikoerper, AI836096 antikoerper, cb345 antikoerper, etID36982.3 antikoerper, gfapl antikoerper, wu:fb34h11 antikoerper, wu:fk42c12 antikoerper, xx:af506734 antikoerper, zgc:110485 antikoerper, glial fibrillary acidic protein antikoerper, GFAP antikoerper, LOC100136168 antikoerper, gfap antikoerper, Gfap antikoerper
    Hintergrund
    GFAP is one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system.Synonyms: Glial Fibrillary Acidic Protein
    Molekulargewicht
    49880 Da
    Gen-ID
    2670
    NCBI Accession
    NP_001124491
    UniProt
    P14136
Sie sind hier:
Kundenservice